115 related articles for article (PubMed ID: 31576529)
1. Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human Cancer.
Swenson SD; Silva-Hirschberg C; Markland FS
Methods Mol Biol; 2020; 2068():185-204. PubMed ID: 31576529
[TBL] [Abstract][Full Text] [Related]
2. A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice.
Swenson S; Minea RO; Tuan CD; Thein TZ; Chen TC; Markland FS
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413113
[TBL] [Abstract][Full Text] [Related]
3. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of a
Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
[TBL] [Abstract][Full Text] [Related]
5. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
Swenson S; Costa F; Ernst W; Fujii G; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
[TBL] [Abstract][Full Text] [Related]
6. Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.
Minea RO; Helchowski CM; Zidovetzki SJ; Costa FK; Swenson SD; Markland FS
PLoS One; 2010 Jun; 5(6):e10929. PubMed ID: 20532165
[TBL] [Abstract][Full Text] [Related]
7. Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.
Minea R; Helchowski C; Rubino B; Brodmann K; Swenson S; Markland F
Toxicon; 2012 Mar; 59(4):472-86. PubMed ID: 21354198
[TBL] [Abstract][Full Text] [Related]
8. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression.
Swenson S; Costa F; Minea R; Sherwin RP; Ernst W; Fujii G; Yang D; Markland FS
Mol Cancer Ther; 2004 Apr; 3(4):499-511. PubMed ID: 15078994
[TBL] [Abstract][Full Text] [Related]
9. Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro.
Schmitmeier S; Markland FS; Ritter MR; Sawcer DE; Chen TC
Cell Commun Adhes; 2003; 10(1):1-16. PubMed ID: 12881036
[TBL] [Abstract][Full Text] [Related]
10. A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model.
Markland FS; Shieh K; Zhou Q; Golubkov V; Sherwin RP; Richters V; Sposto R
Haemostasis; 2001; 31(3-6):183-91. PubMed ID: 11910184
[TBL] [Abstract][Full Text] [Related]
11. Snake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrins.
Lu X; Lu D; Scully MF; Kakkar VV
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):249-60. PubMed ID: 15974889
[TBL] [Abstract][Full Text] [Related]
12. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor formation by snake venom disintegrin.
Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM
Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenesis and RGD-containing snake venom disintegrins.
Swenson S; Ramu S; Markland FS
Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
[TBL] [Abstract][Full Text] [Related]
16. Multimeric disintegrin protein polymer fusions that target tumor vasculature.
Janib SM; Gustafson JA; Minea RO; Swenson SD; Liu S; Pastuszka MK; Lock LL; Cui H; Markland FS; Conti PS; Li Z; MacKay JA
Biomacromolecules; 2014 Jul; 15(7):2347-58. PubMed ID: 24871936
[TBL] [Abstract][Full Text] [Related]
17. Anti-thrombotic agents derived from snake venom proteins.
Huang TF; Hsu CC; Kuo YJ
Thromb J; 2016; 14(Suppl 1):18. PubMed ID: 27766044
[TBL] [Abstract][Full Text] [Related]
18. The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model.
Pyrko P; Wang W; Markland FS; Swenson SD; Schmitmeier S; Schönthal AH; Chen TC
J Neurosurg; 2005 Sep; 103(3):526-37. PubMed ID: 16235686
[TBL] [Abstract][Full Text] [Related]
19. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis.
Trikha M; De Clerck YA; Markland FS
Cancer Res; 1994 Sep; 54(18):4993-8. PubMed ID: 7520832
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Vipera Anatolica Venom Disintegrin via Intracellular Uptake with Radiolabeling Study and Cell-Based Electrochemical Biosensing Assay.
Er O; Eksin E; Soylu HM; Göçmen B; Nalbantsoy A; Yurt F; Erdem A
Appl Biochem Biotechnol; 2019 Apr; 187(4):1539-1550. PubMed ID: 30276529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
